| BP | Bachelor of Pharmacy; back pressure; barometric pressure; basic protein; bathroom privileges; bed pa... |
|---|---|
| CFPP | craniofacial pattern profile |
| CLIP | capitolunate instability pattern; corticotropin-like intermediate lobe peptide |
| Dp | pattern difference |
| EEGV1 | electroencephalographic variant pattern 1 |
| juvenile pattern | A precordial T-wave inversion, sometimes with J-ST elevations in an electrocardiogram, resembling that seen in normal children, which occurs as a normal variant in some adults, especially blacks, and especially in leads V1, V2, and V3. (05 Mar 2000) |
|---|---|
| female pattern alopecia | Diffuse partial hair loss in the centroparietal area of the scalp, with preservation of the frontal and temporal hair lines; the most frequent type of androgenic alopecia in women. (05 Mar 2000) |
| female pattern baldness | <dermatology> Hair loss in women that may be associated with aging, hormones (androgens) or genetic predisposition. The pattern of baldness in women is different from that of men. In women there is thinning of the hair all over the scalp, but the frontal hairline is maintained. The hair loss is usually permanent. Treatment has been successful with topical minoxidil in some cases. (27 Sep 1997) |
| acquired immunity | <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent. These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack. Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction. (13 Nov 1997) |
| active immunity | <immunology> An organisms resistance to disease or infection, developed because the organisms immune system has produced antibodies after an infection or innoculation. (06 May 1997) |
| adoptive immunity | <immunology> Immunity to disease or infection conferred on a previously non-immune individual by transferring lymphocytes from a previously immune individual to the non-immune individual. (15 Jan 1998) |
| allograft immunity | <immunology> The recipient's immune system rejects tissue grafted from a genetically dissimilar donor (of the same species) and stages an immune attack against it. (09 Oct 1997) |
| antiviral immunity | Immunity resulting from virus infection, either naturally acquired or produced by intentional vaccination; compared to some bacterial immunity's, it is of relatively long duration, but this may be the result of infection-immunity rather than being peculiar to virus infection per se, since it occurs also in bacterial immunity after infections such as typhoid fever. (05 Mar 2000) |
| artificial active immunity | See: acquired immunity. (05 Mar 2000) |
| artificial passive immunity | See: acquired immunity. (05 Mar 2000) |
| bacteriophage immunity | The state induced in a bacterium by lysogenization, the lysogenic bacterium being insusceptible to further lysogenization or to a lytic cycle by a superinfecting bacteriophage, in contradistinction to bacteriophage resistance. (05 Mar 2000) |
| general immunity | Immunity associated with widely diffused mechanisms that tend to protect the body as a whole, as compared with local immunity. (05 Mar 2000) |
| maternal immunity | <epidemiology> Immunity for a neonate provided by IgG antibody generated by a mother and passed across the placenta to the unborn offspring. This provides short lived protection (with a typical half life of 3-6 months) to the neonate. Also known as immunity. (05 Dec 1998) |
| passive immunity | <immunology> Immunity acquired by the transfer from another animal of antibody or sensitised lymphocytes. Passive transfer of antibody from mother to offspring is important for immune defense during the perinatal period. (18 Nov 1997) |
| relative immunity | A modified, not completely effective resistance that results when there is a sort of "fluctuating equilibrium" between the defense mechanisms of the host and the infective agent. (05 Mar 2000) |